{"transactions":[{"id":1590096,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":false,"shares":4640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Grant of option to buy 6,003 shares of Issuer common stock that vest in four annual installments beginning February 14, 2022."}],"balance_after":1363,"derivative":{"exercise_price":544.08,"expiration_date":"2031-02-13","underlying":"Common Stock","underlying_shares":4640},"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590095,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":false,"shares":2226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021."}],"balance_after":0,"derivative":{"exercise_price":288.78,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":2226},"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590094,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":false,"shares":483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024."}],"balance_after":0,"derivative":{"exercise_price":206.94,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":483},"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590093,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":false,"shares":755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020."}],"balance_after":0,"derivative":{"exercise_price":206.94,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":755},"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590092,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":680,"price":559.3318,"value":380345.624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold ranging from a low of $559.51 to a high of $559.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":10711.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590091,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":3290,"price":558.8822,"value":1838722.438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold ranging from a low of $558.45 to a high of $559.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":11391.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590090,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":4134,"price":557.941,"value":2306528.094,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold ranging from a low of $557.33 to a high of $558.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":14681.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590089,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":true,"shares":4640,"price":544.08,"value":2524531.2,"ownership":{"direct":true},"balance_after":18815.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590088,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":true,"shares":2226,"price":288.78,"value":642824.28,"ownership":{"direct":true},"balance_after":14175.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590087,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":true,"shares":483,"price":206.94,"value":99952.02,"ownership":{"direct":true},"balance_after":11949.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1590086,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-03-07T22:00:38.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":true,"shares":755,"price":206.94,"value":156239.7,"ownership":{"direct":true},"balance_after":11466.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000065","document":"wk-form4_1709848825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000065/wk-form4_1709848825.xml","form_type":"4"}},{"id":1639633,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."}],"balance_after":660,"derivative":{"underlying":"Common Stock","underlying_shares":220},"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639632,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."}],"balance_after":408,"derivative":{"underlying":"Common Stock","underlying_shares":204},"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639631,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."}],"balance_after":160,"derivative":{"underlying":"Common Stock","underlying_shares":161},"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639630,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":216},"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639629,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":126},"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639628,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":279,"price":560.56,"value":156396.24,"ownership":{"direct":true},"balance_after":10711.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639627,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":220,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10990.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639626,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":204,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10770.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639625,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":161,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10566.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639624,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":216,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10405.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1639623,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:57:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13.2470 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023."}],"balance_after":10189.2345,"source":{"system":"sec-edgar","filing":"0000874716-24-000041","document":"wk-form4_1708124235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000041/wk-form4_1708124235.xml","form_type":"4"}},{"id":1718428,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"exercise","planned":false,"acquired":false,"shares":6680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021."}],"balance_after":2226,"derivative":{"exercise_price":288.78,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":6680},"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1718427,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"exercise","planned":false,"acquired":false,"shares":4956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020."}],"balance_after":755,"derivative":{"exercise_price":206.94,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":4956},"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1718426,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"sale","planned":false,"acquired":false,"shares":3940,"price":523.5563,"value":2062811.822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average price of the shares sold ranging from a low of $523.05 to a high of $523.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":10049.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1718425,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"sale","planned":false,"acquired":false,"shares":1202,"price":522.3094,"value":627815.8988,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of the shares sold ranging from a low of $521.99 to a high of $522.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":13989.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1718424,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"sale","planned":false,"acquired":false,"shares":3378,"price":521.0046,"value":1759953.5388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold ranging from a low of $520.74 to a high of $521.235 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":15191.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1718423,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"sale","planned":false,"acquired":false,"shares":3116,"price":520.1922,"value":1620918.8952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold ranging from a low of $519.73 to a high of $520.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":18569.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1718422,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"exercise","planned":false,"acquired":true,"shares":6680,"price":288.78,"value":1929050.4,"ownership":{"direct":true},"balance_after":21685.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1718421,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-12-08T22:00:21.000Z","date":"2023-12-07","kind":"exercise","planned":false,"acquired":true,"shares":4956,"price":206.94,"value":1025594.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023."}],"balance_after":15005.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000145","document":"wk-form4_1702072812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000145/wk-form4_1702072812.xml","form_type":"4"}},{"id":1792343,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":false,"shares":5865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Grant of option to buy 5,865 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019."}],"balance_after":0,"derivative":{"exercise_price":178.26,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":5865},"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792342,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":false,"shares":560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023."}],"balance_after":0,"derivative":{"exercise_price":178.26,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":560},"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792341,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":false,"shares":7151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Grant of option to buy 7,151 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018."}],"balance_after":0,"derivative":{"exercise_price":141.6,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":7151},"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792340,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":false,"shares":706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022."}],"balance_after":0,"derivative":{"exercise_price":141.6,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":706},"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792339,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":false,"shares":2627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Grant of option to buy 12,627 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017."}],"balance_after":0,"derivative":{"exercise_price":68.75,"expiration_date":"2026-02-13","underlying":"Common Stock","underlying_shares":2627},"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792338,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":2887,"price":511.2237,"value":1475902.8219,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average price of the shares sold ranging from a low of $510.96 to a high of $511.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":10037.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792337,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":7473,"price":511.0286,"value":3818916.7278,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average price of the shares sold ranging from a low of $510.73 to a high of $511.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":12924.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792336,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":3318,"price":510.4664,"value":1693727.5152,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average price of the shares sold ranging from a low of $509.93 to a high of $510.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":20397.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792335,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":6186,"price":510.3776,"value":3157195.8336,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of the shares sold ranging from a low of $509.69 to a high of $510.68 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":23715.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792334,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":2545,"price":509.3207,"value":1296221.1815,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold ranging from a low of $508.63 to a high of $509.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":29901.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792333,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"sale","planned":false,"acquired":false,"shares":500,"price":508.9642,"value":254482.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold ranging from a low of $508.76 to a high of $509.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":32446.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792332,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":true,"shares":5865,"price":178.26,"value":1045494.9,"ownership":{"direct":true},"balance_after":32946.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792331,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":true,"shares":560,"price":178.26,"value":99825.6,"ownership":{"direct":true},"balance_after":27081.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792330,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":true,"shares":7151,"price":141.6,"value":1012581.6,"ownership":{"direct":true},"balance_after":26521.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792329,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":true,"shares":706,"price":141.6,"value":99969.6,"ownership":{"direct":true},"balance_after":19370.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":1792328,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-08-31T21:17:05.000Z","date":"2023-08-29","kind":"exercise","planned":false,"acquired":true,"shares":2627,"price":68.75,"value":180606.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023."}],"balance_after":18664.9875,"source":{"system":"sec-edgar","filing":"0000874716-23-000113","document":"wk-form4_1693516123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000113/wk-form4_1693516123.xml","form_type":"4"}},{"id":2012223,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":204,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."}],"balance_after":2155,"derivative":{"underlying":"Common Stock","underlying_shares":204},"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012222,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":161,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."}],"balance_after":2359,"derivative":{"underlying":"Common Stock","underlying_shares":161},"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012221,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":216,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in four annual installments, beginning February 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in four annual installments, beginning February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in four annual installments, beginning February 14, 2021."}],"balance_after":2520,"derivative":{"underlying":"Common Stock","underlying_shares":216},"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012220,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":127,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2020."}],"balance_after":2736,"derivative":{"underlying":"Common Stock","underlying_shares":127},"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012219,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":126,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2019."}],"balance_after":2863,"derivative":{"underlying":"Common Stock","underlying_shares":126},"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012218,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"tax_withholding","acquired":true,"shares":252,"price":503.65,"value":126919.8,"ownership":{"direct":true},"balance_after":16011.2845,"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012217,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":204,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16263.2845,"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012216,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":161,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16605.2845,"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012215,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":216,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15898.2845,"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012214,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":127,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15682.2845,"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2012213,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:54:36.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Adjusted to include 1 additional share of Issuer common stock due to a scrivener's error."}],"balance_after":15555.2845,"source":{"system":"sec-edgar","filing":"0001567619-23-003221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003221/doc1.xml","form_type":"4"}},{"id":2023694,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T22:03:30.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":880,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."}],"balance_after":2989,"derivative":{"underlying":"Common Stock","underlying_shares":880},"source":{"system":"sec-edgar","filing":"0001567619-23-002395","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923002395/doc1.xml","form_type":"4"}},{"id":2023693,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2023-02-10T22:03:30.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2027."}],"balance_after":201,"derivative":{"exercise_price":497.43,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":201},"source":{"system":"sec-edgar","filing":"0001567619-23-002395","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923002395/doc1.xml","form_type":"4"}},{"id":2023692,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-02-10T22:03:30.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":6236,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2024."}],"balance_after":6236,"derivative":{"exercise_price":497.43,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":6236},"source":{"system":"sec-edgar","filing":"0001567619-23-002395","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923002395/doc1.xml","form_type":"4"}},{"id":2392978,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":161,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."}],"balance_after":2109,"derivative":{"underlying":"Common Stock","underlying_shares":161},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392977,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":217,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021."}],"balance_after":2270,"derivative":{"underlying":"Common Stock","underlying_shares":217},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392976,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":127,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2020."}],"balance_after":2487,"derivative":{"underlying":"Common Stock","underlying_shares":127},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392975,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":126,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2019."}],"balance_after":2614,"derivative":{"underlying":"Common Stock","underlying_shares":126},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392974,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":150,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2018."}],"balance_after":2740,"derivative":{"underlying":"Common Stock","underlying_shares":150},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392973,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":816,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."}],"balance_after":2890,"derivative":{"underlying":"Common Stock","underlying_shares":816},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392972,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":197,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant."}],"balance_after":197,"derivative":{"exercise_price":505.53,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":197},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392971,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":7009,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023."}],"balance_after":7009,"derivative":{"exercise_price":505.53,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":7009},"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392970,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":true,"shares":235,"price":505.53,"value":118799.55,"ownership":{"direct":true},"balance_after":15374.2845,"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392969,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":161,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15609.2845,"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392968,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":217,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15448.2845,"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392967,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":127,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15231.2845,"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392966,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":126,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15104.2845,"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2392965,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-02-17T00:26:27.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2021."}],"balance_after":14978.2845,"source":{"system":"sec-edgar","filing":"0001567619-22-004785","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004785/doc1.xml","form_type":"4"}},{"id":2491217,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-12-01T22:01:23.000Z","date":"2021-11-29","kind":"sale","acquired":false,"shares":4595,"price":633,"value":2908635.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Updated to correct a scrivener's error in the Form 4 filed on August 25, 2021, which inadvertently reported the total amount of beneficially owned securities following the reported transaction as 19,494.2845 instead of 19,404.2845. Also includes 9 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021."}],"balance_after":14818.2845,"source":{"system":"sec-edgar","filing":"0001567619-21-021392","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921021392/doc1.xml","form_type":"4"}},{"id":2591532,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-08-25T21:00:31.000Z","date":"2021-08-23","kind":"gift","acquired":false,"shares":522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 11.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021."}],"balance_after":19494.2845,"source":{"system":"sec-edgar","filing":"0001567619-21-016332","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921016332/doc1.xml","form_type":"4"}},{"id":2690048,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"exercise","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Grant of option to buy 12,627 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2017."}],"balance_after":2627,"derivative":{"exercise_price":67.85,"expiration_date":"2026-02-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690047,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":200,"price":565.555,"value":113111.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average price of the shares sold ranging from a low of $565.42 to a high of $565.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":19915,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690046,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":513,"price":564.7257,"value":289704.2841,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average price of the shares sold ranging from a low of $564.38 to a high of $564.88 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":20115,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690045,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":1713,"price":564.0384,"value":966197.7792,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average price of the shares sold ranging from a low of $563.36 to a high of $564.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":20628,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690044,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":2462,"price":562.6535,"value":1385252.917,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average price of the shares sold ranging from a low of $562.26 to a high of $563.155 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":22341,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690043,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":1429,"price":561.771,"value":802770.759,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average price of the shares sold ranging from a low of $561.25 to a high of $562.24 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":24803,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690042,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":1274,"price":560.7933,"value":714450.6642,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of the shares sold ranging from a low of $560.24 to a high of $561.24 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":26232,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690041,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":1370,"price":559.7656,"value":766878.872,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold ranging from a low of $559.23 to a high of $560.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":27506,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690040,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":1039,"price":558.8934,"value":580690.2426,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold ranging from a low of $558.22 to a high of $559.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2690039,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-06-01T22:01:04.000Z","date":"2021-05-28","kind":"exercise","acquired":true,"shares":10000,"price":67.85,"value":678500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 12 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021."}],"balance_after":29915,"source":{"system":"sec-edgar","filing":"0001567619-21-011452","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921011452/doc1.xml","form_type":"4"}},{"id":2828059,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2021-03-01T22:05:51.000Z","date":"2021-02-25","kind":"exercise","acquired":false,"shares":1476,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2021."}],"balance_after":0,"derivative":{"exercise_price":67.85,"expiration_date":"2026-02-13","underlying":"Common Stock","underlying_shares":1476},"source":{"system":"sec-edgar","filing":"0001567619-21-005196","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921005196/doc1.xml","form_type":"4"}},{"id":2828058,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-03-01T22:05:51.000Z","date":"2021-02-25","kind":"exercise","acquired":true,"shares":1476,"price":67.85,"value":100146.6,"ownership":{"direct":true},"balance_after":19903,"source":{"system":"sec-edgar","filing":"0001567619-21-005196","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921005196/doc1.xml","form_type":"4"}},{"id":2856444,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":217,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four  annual installments, beginning February 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four  annual installments, beginning February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four  annual installments, beginning February 14, 2021."}],"balance_after":2074,"derivative":{"underlying":"Common Stock","underlying_shares":217},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856443,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":127,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020."}],"balance_after":2291,"derivative":{"underlying":"Common Stock","underlying_shares":127},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856442,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":126,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2019."}],"balance_after":2418,"derivative":{"underlying":"Common Stock","underlying_shares":126},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856441,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":150,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in five annual installments, beginning February 14, 2018."}],"balance_after":2544,"derivative":{"underlying":"Common Stock","underlying_shares":150},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856440,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":243,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested  in five annual installments, beginning  February 14, 2017."}],"balance_after":2694,"derivative":{"underlying":"Common Stock","underlying_shares":243},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856439,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":643,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022."}],"balance_after":2937,"derivative":{"underlying":"Common Stock","underlying_shares":643},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856438,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant."}],"balance_after":183,"derivative":{"exercise_price":544.08,"expiration_date":"2031-02-13","underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856437,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":6003,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022."}],"balance_after":6003,"derivative":{"exercise_price":544.08,"expiration_date":"2031-02-13","underlying":"Common Stock","underlying_shares":6003},"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856436,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"tax_withholding","acquired":false,"shares":257,"price":544.08,"value":139828.56,"ownership":{"direct":true},"balance_after":18427,"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856435,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":true,"shares":217,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18684,"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856434,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":true,"shares":127,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18467,"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}},{"id":2856433,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":93398,"kind":"person","name":"POLEWACZYK JAMES F","position":1,"cik":"0001389046","reported_name":"POLEWACZYK JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2021-02-18T00:34:08.000Z","date":"2021-02-14","kind":"exercise","acquired":true,"shares":126,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18340,"source":{"system":"sec-edgar","filing":"0001567619-21-004327","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921004327/doc1.xml","form_type":"4"}}],"next_cursor":"2021-02-18T00:34:08.000000Z,2856433"}